
Sign up to save your podcasts
Or
This week Shanti and Elliot discuss the data behind Biogen's recent decision to revive their Aducanumab study.
4.5
3030 ratings
This week Shanti and Elliot discuss the data behind Biogen's recent decision to revive their Aducanumab study.